Sone Capital Management, LLC

Position in ABT — Abbott Laboratories

CIK 2026215 NEW YORK, NY

Position in ABT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,592,488

+$3,479,220 QoQ

Shares Held

83,673

+108.9% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.58%

of 13F equity value

Holder Rank

#572

of 2,966 holders

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Sone Capital Management, LLC holds $24,426,533 across 6 Medical Devices names. ABT ranks #1 (31.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories This page	83,673	$7,592,488
2	SYK	Stryker Corp	22,151	$6,974,020
3	STE	STERIS plc	23,016	$4,846,479
4	DXCM	Dexcom Inc	33,380	$2,248,143
5	LAB	Standard Biotools Inc.	2,133,631	$1,749,577
6	BSX	Boston Scientific Corp	23,801	$1,015,826

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,592,488	83,673	+108.9%	Shares	Sole	2026-08-14
2026-03-31	$4,113,268	40,063	+788.5%	Shares	Sole	2026-05-15
2025-12-31	$564,932	4,509	-96.1%	Shares	Sole	2026-02-17
2025-06-30	$15,867,878	116,667	+640.5%	Shares	Sole	2025-08-14
2025-03-31	$2,089,900	15,755	-85.9%	Shares	Sole	2025-05-15
2024-12-31	$12,651,240	111,849	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.